Damora Therapeutics, Inc.
$29.00
-1.60 (-5.23%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -0.7%
- 3 Months
- +16.6%
- YTD
- +26.0%
- 1 Year
- +763.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 474.5%
- Largest decline max drawdown, since Aug 2025
- -72.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.37
Own DMRA?
See how DMRA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.